VKORC1L1 overexpression significantly attenuated tumor growth suppression in p53 wild-type tumors but not in p53-null tumors, suggesting a new pathway for p53-controlled ferroptosis and tumor growth inhibition mediated by vitamin K metabolism modulation. Here, VKORC1L1 is linked to neoplasm.